Tvr Pharmaceuticals Private Limited
Founded in 2019 and headquartered in Telangana, India.
2019 | Hyderabad, Telangana (India) | Active
Tvr Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 48.30%
- Profit Growth -9.48%
- Ebitda -1.33%
- Net Worth 36.26%
- Total Assets 43.75%
About Tvr Pharmaceuticals
Tvr Pharmaceuticals Private Limited (TPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 11 October 2019 (Five years and four months 20 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkatravamma Thumati and Naga Thumati serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239TG2019PTC136004
- Company No.
136004
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Chemicals
Pharmaceuticals
Who are the key members and board of directors at Tvr Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatravamma Thumati  | Director | 11-Oct-2019 | Current |
| Naga Thumati | Director | 11-Oct-2019 | Current |
Financial Performance of Tvr Pharmaceuticals.
Tvr Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.3% increase. The company also saw a slight decrease in profitability, with a 9.48% decrease in profit. The company's net worth Soared by an impressive increase of 36.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tvr Pharmaceuticals?
Unlock access to Tvr Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tvr Pharmaceuticals?
Unlock and access historical data on people associated with Tvr Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tvr Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tvr Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.